Further studies on ECFC from HHT patients revealed impaired ALK1- and ALK5-dependent TGF-β signaling, which promotes fragility of small vessels and vascular lesions; these may contribute to the clinical symptoms associated with this disease (34, 35). Here, TGFB1 is linked to hereditary hemorrhagic telangiectasia.